29.04.2024 08:06:38 - dpa-AFX: *ASTRAZENECA SAYS TRUQAP + FASLODEX RECOMMENDED FOR APPROVAL IN EU FOR PATIENTS WITH ADVANCED ER-POSITIVE BREAST CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Xetra 148,800 14.06.24 16:57:49 +1,850 +1,26% 148,750 148,850 148,100 146,950

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH